Antitumor activities of Chemerin have been identified in a murine model of breast cancer, where it binds to its receptor ChemR23/CMKLR1 and inhibits neovascularization, thereby suppressing growth and invasion of breast cancer cells (148). This evidence concerns the gene CMKLR1 and breast carcinoma.